Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma Munich, Germany, May 21, 2015 – Isarna Therapeutics, the leader in transforming growth factor beta (TGF-β) i - Munich - Document - PDFSEARCH.IO

First Page	Meta Content
	Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma Munich, Germany, May 21, 2015 – Isarna Therapeutics, the leader in transforming growth factor beta (TGF-β) i Add to Reading List Document Date: 2015-05-21 05:13:28 Open Document File Size: 194,30 KB Share Result on Facebook

Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma Munich, Germany, May 21, 2015 – Isarna Therapeutics, the leader in transforming growth factor beta (TGF-β) iAdd to Reading List